518 related articles for article (PubMed ID: 11646923)
1. Risky alliance on medicine's cutting edge: firm faces business, ethics issues in NIH joint venture.
Lehrman S
Washington Post; 1991 Aug; ():Business 1, 14. PubMed ID: 11646923
[No Abstract] [Full Text] [Related]
2. Public-private partnerships in biomedical research: resolving conflicts arising under the Federal Technology Transfer Act of 1986.
Bulleit TN
J Law Health; 1989-1990; 4(1):1-20. PubMed ID: 11652568
[No Abstract] [Full Text] [Related]
3. Health chief assails a research deal.
Hilts PJ
N Y Times Web; 1993 Mar; ():A12. PubMed ID: 11646979
[No Abstract] [Full Text] [Related]
4. University physician-researcher conflicts of interest: the inadequacy of current controls and proposed reform.
Maatz CT
High Technol Law J; 1992; 7():137-88. PubMed ID: 11659962
[No Abstract] [Full Text] [Related]
5. Should AIDS research be regulated? A Manhattan Project for AIDS and other policy proposals.
Salbu SR
Indiana Law J; 1994; 69(2):425-75. PubMed ID: 11652751
[No Abstract] [Full Text] [Related]
6. FDA issues concerning conflicts of interest.
Kurt TL
IRB; 1990; 12(5):6-9. PubMed ID: 11654003
[No Abstract] [Full Text] [Related]
7. Panel that reviews gene tests in humans has no applications.
Weiss R
Washington Post; 1996 Feb; ():A3. PubMed ID: 11647100
[No Abstract] [Full Text] [Related]
8. Conflicts of interest.
Nature; 1989 Aug; 340(6236):664. PubMed ID: 11644385
[No Abstract] [Full Text] [Related]
9. Ethical values in the education of biomedical researchers.
Heitman E
Hastings Cent Rep; 2000; 30(4 Suppl):S40-4. PubMed ID: 11658244
[No Abstract] [Full Text] [Related]
10. New rules will force doctors to disclose ties to drug industry.
Stolberg SG
N Y Times Web; 1998 Feb; ():A12. PubMed ID: 11647602
[No Abstract] [Full Text] [Related]
11. Encouraging accountability in research: a pilot assessment of training efforts.
Mastroianni AC; Kahn JP
Account Res; 1999; 7(1):85-100. PubMed ID: 11657564
[No Abstract] [Full Text] [Related]
12. Profits and ethics clash in research on genetic coding.
Fisher LM
N Y Times Web; 1994 Jan; ():1, 18. PubMed ID: 11647947
[No Abstract] [Full Text] [Related]
13. In search of funding: the clinical investigator and the drug company; Commentary: why researchers need not be demoralized.
Siris ES; Burrell CD
IRB; 1983; 5(6):1-5. PubMed ID: 11649526
[No Abstract] [Full Text] [Related]
14. Gene-splice oversight.
Parens E
Washington Post; 1996 Jun; ():A21. PubMed ID: 11646331
[No Abstract] [Full Text] [Related]
15. Pitching doctors.
Wilkes MS; Shuchman M
N Y Times Mag; 1989 Nov; ():88, 90, 126, 128-129. PubMed ID: 11650264
[No Abstract] [Full Text] [Related]
16. If only it were so: medical physics, U.S. human radiation experiments, and the Final Report of the President's Advisory Committee (ACHRE).
Martensen R
Med Humanit Rev; 1997; 11(2):21-36. PubMed ID: 11645853
[No Abstract] [Full Text] [Related]
17. In business to treat cancer.
Henig RM
N Y Times Mag; 1986 Nov; ():68, 70, 78, 80+. PubMed ID: 11647805
[No Abstract] [Full Text] [Related]
18. Ethical issues in funding and monitoring university research.
Beauchamp TL
Bus Prof Ethics J; 1992; 11(1):5-16. PubMed ID: 11659431
[No Abstract] [Full Text] [Related]
19. Money is putting people at risk in biomedical research.
Andrews LB
Chron High Educ; 2000 Mar; 46(27):B1, B4-5. PubMed ID: 11657699
[No Abstract] [Full Text] [Related]
20. Secrets of the artificial heart business.
Anderson I
New Sci; 1984 Dec; 104(1433):7. PubMed ID: 11655657
[No Abstract] [Full Text] [Related]
[Next] [New Search]
